Fondaparinux in heparin-induced thrombocytopenia: A decade's worth of clinical experience.
作者信息
Schindewolf Marc
机构信息
Swiss Cardiovascular Center Division of Vascular Medicine University Hospital Bern Bern Switzerland.
出版信息
Res Pract Thromb Haemost. 2018 Dec 4;3(1):9-11. doi: 10.1002/rth2.12169. eCollection 2019 Jan.
Abstract
摘要
相似文献
1
Fondaparinux in heparin-induced thrombocytopenia: A decade's worth of clinical experience.磺达肝癸钠用于肝素诱导的血小板减少症：十年临床经验
Res Pract Thromb Haemost. 2018 Dec 4;3(1):9-11. doi: 10.1002/rth2.12169. eCollection 2019 Jan.
2
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia.肝素诱导的血小板减少症（HIT）的临床特征及其与非 HIT 性血小板减少症的鉴别。
Thromb Haemost. 2016 Oct 28;116(5):813-822. doi: 10.1160/TH16-06-0435. Epub 2016 Sep 22.
3
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.使用非标签外或批准的抗凝剂治疗肝素诱导的血小板减少症。
J Am Coll Cardiol. 2017 Nov 28;70(21):2636-2648. doi: 10.1016/j.jacc.2017.09.1099.
4
Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia.比较阿加曲班和磺达肝癸钠治疗肝素诱导的血小板减少症患者。
Ann Hematol. 2018 Nov;97(11):2055-2059. doi: 10.1007/s00277-018-3422-6. Epub 2018 Jul 12.
5
Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.磺达肝癸钠用于一名肝素诱导的血小板减少症危重症患者：病例报告。
Medicine (Baltimore). 2018 Sep;97(37):e12236. doi: 10.1097/MD.0000000000012236.
6
Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.低剂量磺达肝癸钠用于危重症患者疑似肝素诱导的血小板减少症
Neth J Med. 2007 Mar;65(3):101-8.
7
Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol.新型磺达肝素钠抗凝方案在肾衰竭伴疑似肝素诱导血小板减少症成人患者中的应用：对机构方案的回顾性研究。
BMC Pharmacol Toxicol. 2023 Jan 13;24(1):2. doi: 10.1186/s40360-023-00643-4.
8
Successful use of fondaparinux in a patient with a mechanical heart valve replacement and a history of heparin-induced thrombocytopenia.成功使用磺达肝癸钠治疗机械心脏瓣膜置换术后伴肝素诱导血小板减少症病史的患者。
J Thromb Thrombolysis. 2010 Oct;30(3):375-7. doi: 10.1007/s11239-010-0494-0.
9
Heparin-induced thrombocytopenia treated with fondaparinux: single center experience.使用磺达肝癸钠治疗肝素诱导的血小板减少症：单中心经验
Int Angiol. 2020 Feb;39(1):76-81. doi: 10.23736/S0392-9590.19.04247-0. Epub 2019 Nov 25.
10
Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.在一名患有磺达肝癸钠相关性血小板减少症的患者中，磺达肝癸钠在体外与肝素抗体发生交叉反应。
Blood Coagul Fibrinolysis. 2011 Jan;22(1):76-8. doi: 10.1097/MBC.0b013e328340ff24.
引用本文的文献
1
Thrombocytopenia and Anemia After Cardiac Surgery.心脏手术后的血小板减少症和贫血症
Am J Hematol. 2025 Aug;100(8):1425-1431. doi: 10.1002/ajh.27696. Epub 2025 May 2.
本文引用的文献
1
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.美国血液学会 2018 年静脉血栓栓塞症管理指南：肝素诱导的血小板减少症。
Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489.
2
Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials.磺达肝癸钠用于肝素诱导的血小板减少症的系统评价：在无随机对照试验的情况下
Res Pract Thromb Haemost. 2018 Aug 9;2(4):678-683. doi: 10.1002/rth2.12145. eCollection 2018 Oct.
3
Heparin-induced thrombocytopenia: A critical appraisal of clinical practice guidelines with the AGREE II instrument.肝素诱导的血小板减少症：AGREE II 工具对临床实践指南的批判性评估。
Thromb Res. 2018 Jun;166:10-18. doi: 10.1016/j.thromres.2018.03.017. Epub 2018 Mar 27.
4
Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.使用非标签外或批准的抗凝剂治疗肝素诱导的血小板减少症。
J Am Coll Cardiol. 2017 Nov 28;70(21):2636-2648. doi: 10.1016/j.jacc.2017.09.1099.
5
Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States.美国抗凝剂用于疑似肝素诱导的血小板减少症的成本效益分析
Blood. 2016 Dec 29;128(26):3043-3051. doi: 10.1182/blood-2016-07-728030. Epub 2016 Oct 28.
6
Overtreatment of Heparin-Induced Thrombocytopenia in the Surgical ICU.外科重症监护病房肝素诱导的血小板减少症的过度治疗。
Crit Care Med. 2017 Jan;45(1):28-34. doi: 10.1097/CCM.0000000000002002.
7
Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.利伐沙班治疗疑似或确诊肝素诱导血小板减少症研究。
J Thromb Haemost. 2016 Jun;14(6):1206-10. doi: 10.1111/jth.13330. Epub 2016 May 10.
8
Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study.4Ts 评分联合 PF4/H-PaGIA 检测在肝素诱导血小板减少症诊断和管理中的应用：前瞻性队列研究。
Blood. 2015 Jul 30;126(5):597-603. doi: 10.1182/blood-2014-12-618165. Epub 2015 Apr 29.
9
Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study.磺达肝癸钠治疗肝素诱导的血小板减少症疑似患者：一项倾向评分匹配研究。
Blood. 2015 Feb 5;125(6):924-9. doi: 10.1182/blood-2014-09-599498. Epub 2014 Dec 16.
10
Voting with your fondaparinux.
Thromb Res. 2014 Jul;134(1):3-4. doi: 10.1016/j.thromres.2014.03.045. Epub 2014 Apr 1.
Zotero 插件